Label: LIDENZA PATCH- lidocaine hydrochloride patch

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated November 15, 2014

If you are a consumer or patient please visit this version.

  • Warnings

    For external use only

    Avoid contact with eyes

    Do not applly to open wounds or damaged skin

    If symptoms persist for more than seven days, discontinue use and consult physician

    If swallowed, consult physician

    Do not bandage tightly

    If pregnant or breast feeding, contact physician prior to use

    Do not use in large quantities, particularly over raw surfaces or blistered areas

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children

  • ACTIVE INGREDIENT

    Lidocaine HCL 4.00%

    Menthol 1.00%

  • INACTIVE INGREDIENT

    aloe barbadensis leaf, water, arnica montan extract, boswella serrata extract, camelia sinensis leaf extract, carbomer, ethylhexylglycerine, glycerine, isopropyl myristate, PEG 8, phenoxyethanol, polysorbate 80, sodium lauryl sulfate, triethanolamine, fd&c blue #1, fd&c yellow #5

  • DOSAGE & ADMINISTRATION

    clean and dry affected area

    remove patch from backing and apply to affected area

    use only one patch at a time, and maximum of four patches/day

    leave patch on affected area for up to 8 hours

    do not use patches for longer than five consecutive days

    children under 12 should consult physician prior to use

  • INDICATIONS & USAGE

    Temporary relief of pain associated with minor cuts, scrapes and minor skin irritations

  • PURPOSE

    Topical anesthetic

    External analgesic

  • Lidenza Patch

    box image

  • INGREDIENTS AND APPEARANCE
    LIDENZA PATCH 
    lidocaine hydrochloride patch
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:69329-017(NDC:49430-017)
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
    MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL1 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    ARNICA MONTANA (UNII: O80TY208ZW)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    BOSWELLIA SACRA WHOLE (UNII: 8O600AZL0W)  
    GREEN TEA LEAF (UNII: W2ZU1RY8B0)  
    CARBOMER 1342 (UNII: 809Y72KV36)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    PEG-8 GLYCERYL ISOSTEARATE (UNII: 74QQ5X3KL1)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    TRIETHANOLAMINE BENZOATE (UNII: M3EN4GC19W)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    FD&C YELLOW NO. 5 (UNII: I753WB2F1M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69329-017-15100 g in 1 PACKAGE
    2NDC:69329-017-25100 g in 1 PACKAGE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/01/2013
    Labeler - Patchwerx Labs, Inc. (079584480)